Embellence Group AB (publ) (EMBELL) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Embellence Group Ab.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.856 Thank you very much, and welcome to Ambulance Group's Q2 report. 00:00:04.856 -- 00:00:09.682 My name is Johan Angen, and I'm the CEO of the group, and together with me today is Colin 00:00:09.682 -- 00:00:12.204 Lydian, who is the CFO. 00:00:12.204 -- 00:00:16.669 Let's start to look at the business and what we achieved in the second quarter of the 00:00:16.669 -- 00:00:21.755 year. During the quarter, we delivered increased sales and EBITDA, and 00:00:21.755 -- 00:00:25.158 we increased both our gross margin and our EBITDA margins. 00:00:25.158 -- 00:00:30.146 And we continued our journey towards our long-term financial goals and our focus on delivering 00:00:30.146 -- 00:00:32.751 profitable growth. 00:00:32.751 -- 00:00:37.799 The organic sales growth in the quarter was 4%, but it was negatively affected 00:00:37.799 -- 00:00:42.948 by exchange rates, with 3%. Hence, the overall group sales numbers came in 00:00:42.948 -- 00:00:48.317 at 193 million Swedish krona, plus 2 million Swedish krona versus 00:00:48.317 -- 00:00:53.493 past year. Exchange rates did have a negative impact on the business 00:00:53.493 -- 00:00:58.241 in Q2, and with the current trends, we expect that pressure continues in the coming quarters, 00:00:58.241 -- 00:01:02.288 which Colin will shed some more light on later on. 00:01:02.288 -- 00:01:07.517 We are continuing making progress towards our long-term EBITDA target of 15%, 00:01:07.517 -- 00:01:13.907 and in the quarter, the total group's EBITDA margin landed at 13.5%, up 0.5 percentage 00:01:13.907 -- 00:01:19.460 points versus past year. delivering an EBITDA of 26 million Swedish krona, 00:01:19.460 -- 00:01:23.085 up 1 million Swedish krona versus past year. 00:01:23.085 -- 00:01:28.352 Q2 is the q...